Abstract
3D pharmacophore modeling is an important computational methodology for ligand-enzyme binding interactions in drug discovery. More specifically, a consensus pharmacophore model derived from diverse ligands is a key determinant upon which the prediction power of computational models is based for designing novel ligands. In this work, by merging the important pharmacophore features based on four classes of covalent FAAH ligands, and then integrating the exclusion volume spheres derived from the crystal structure, we created for the first time an integrated FAAH pharmacophore model to describe the ligand-enzyme binding interactions. This new integrated FAAH pharmacophore model can correctly predict the covalent ligand binding mode, which correlates with the SAR data. The study is expected to provide insights into novel covalent ligand-FAAH binding interactions, and facilitate the design of covalent ligands against FAAH.
Keywords: Covalent, fatty acid amide hydrolase (FAAH), pharmacophore, docking
Current Computer-Aided Drug Design
Title:Integrated Ligand Based Pharmacophore Model Derived from Diverse FAAH Covalent Ligand Classes
Volume: 8 Issue: 4
Author(s): Lingling Shen, Hongwei Huang, Alexandros Makriyannis and Luke S. Fisher
Affiliation:
Keywords: Covalent, fatty acid amide hydrolase (FAAH), pharmacophore, docking
Abstract: 3D pharmacophore modeling is an important computational methodology for ligand-enzyme binding interactions in drug discovery. More specifically, a consensus pharmacophore model derived from diverse ligands is a key determinant upon which the prediction power of computational models is based for designing novel ligands. In this work, by merging the important pharmacophore features based on four classes of covalent FAAH ligands, and then integrating the exclusion volume spheres derived from the crystal structure, we created for the first time an integrated FAAH pharmacophore model to describe the ligand-enzyme binding interactions. This new integrated FAAH pharmacophore model can correctly predict the covalent ligand binding mode, which correlates with the SAR data. The study is expected to provide insights into novel covalent ligand-FAAH binding interactions, and facilitate the design of covalent ligands against FAAH.
Export Options
About this article
Cite this article as:
Shen Lingling, Huang Hongwei, Makriyannis Alexandros and S. Fisher Luke, Integrated Ligand Based Pharmacophore Model Derived from Diverse FAAH Covalent Ligand Classes, Current Computer-Aided Drug Design 2012; 8 (4) . https://dx.doi.org/10.2174/157340912803519615
DOI https://dx.doi.org/10.2174/157340912803519615 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multi-Target Metal-Based Anticancer Agents
Current Topics in Medicinal Chemistry Structure-Activity Relationships of Pyrrole Hydrazones as New Anti-Tuberculosis Agents
Medicinal Chemistry Utilities of Some Carbon Nucleophiles in Heterocyclic Synthesis
Current Organic Chemistry Patent Perspectives for Corticosteroids Based Ophthalmic Therapeutics
Recent Patents on Drug Delivery & Formulation Post-COVID-19 Gastro-Intestinal Disturbances
Reviews on Recent Clinical Trials Targeting the LKB1 Tumor Suppressor
Current Drug Targets Neuropeptide Y1 and Y5 Receptor Antagonists as Potential Anti-Obesity Drugs: Current Status
Mini-Reviews in Medicinal Chemistry Status of Fatty Acids as Skin Penetration Enhancers-A Review
Current Drug Delivery siRNA as a Potential Therapy for COVID-19
Current Drug Delivery subject Index To Volume 5
Combinatorial Chemistry & High Throughput Screening Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?
Current Drug Targets <i>In Silico</i> Investigation of the SARS CoV2 Protease with Thymoquinone, the Major Constituent of <i>Nigella Sativa</i>
Current Drug Discovery Technologies Most Promising Compounds for Treating COVID-19 and Recent Trends in Antimicrobial & Antifungal Agents
Current Topics in Medicinal Chemistry New Therapies for Sepsis
Current Topics in Medicinal Chemistry 5-Sulfonamide Benzimidazoles: A Class of Cannabinoid Receptors Agonists with Potent In Vivo Antinociception Activity
Letters in Drug Design & Discovery Innate Immunity and Microbes: Conversations with the Gut Leading to Intestinal Tissue Repair and Fibrosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Clinical Signs, Prevention and Treatment of Viral Infections in Infants
Infectious Disorders - Drug Targets Editorial from Guest Editor [Hot topic: The Optimal Care of the Lung in the Critically Ill (Guest Editor: Ross Freebairn)]
Current Respiratory Medicine Reviews Exploration of Angiotensin II Type 1 Receptor Modulators by Molecular Fingerprints and Docking Simulations
Letters in Drug Design & Discovery High Throughput Bioassays Using Nanoparticles
Combinatorial Chemistry & High Throughput Screening